These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 28145793)

  • 21. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer.
    Ray S; Ghosh Ray S; Mandal S
    Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles.
    Luo YY; Xiong XY; Cheng F; Gong YC; Li ZL; Li YP
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):711-719. PubMed ID: 28716749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimization of ciprofloxacin complex loaded PLGA nanoparticles for pulmonary treatment of cystic fibrosis infections: Design of experiments approach.
    Günday Türeli N; Türeli AE; Schneider M
    Int J Pharm; 2016 Dec; 515(1-2):343-351. PubMed ID: 27744035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.
    Cun D; Jensen DK; Maltesen MJ; Bunker M; Whiteside P; Scurr D; Foged C; Nielsen HM
    Eur J Pharm Biopharm; 2011 Jan; 77(1):26-35. PubMed ID: 21093589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced properties of discrete pulmonary deoxyribonuclease I (DNaseI) loaded PLGA nanoparticles during encapsulation and activity determination.
    Osman R; Kan PL; Awad G; Mortada N; El-Shamy AE; Alpar O
    Int J Pharm; 2011 Apr; 408(1-2):257-65. PubMed ID: 21335080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Etoposide encapsulation in surface-modified poly(lactide-co-glycolide) nanoparticles strongly enhances glioma antitumor efficiency.
    Callewaert M; Dukic S; Van Gulick L; Vittier M; Gafa V; Andry MC; Molinari M; Roullin VG
    J Biomed Mater Res A; 2013 May; 101(5):1319-27. PubMed ID: 23065812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles.
    Esmaeili F; Hosseini-Nasr M; Rad-Malekshahi M; Samadi N; Atyabi F; Dinarvand R
    Nanomedicine; 2007 Jun; 3(2):161-7. PubMed ID: 17468055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.
    Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW
    Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of differential drying techniques on PLGA nanoparticles containing hydrophobic and hydrophilic anticancer agents.
    Dhapare SS; Dash AK
    Ther Deliv; 2015 Jan; 6(1):27-39. PubMed ID: 25565439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
    Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of polymeric nanoparticles and its applications as drug delivery systems for acne treatment.
    Reis CP; Martinho N; Rosado C; Fernandes AS; Roberto A
    Drug Dev Ind Pharm; 2014 Mar; 40(3):409-17. PubMed ID: 23480566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High glycolic poly (DL lactic co glycolic acid) nanoparticles for controlled release of meropenem.
    Nandakumar V; Geetha V; Chittaranjan S; Doble M
    Biomed Pharmacother; 2013 Jun; 67(5):431-6. PubMed ID: 23583192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of borneol on the pharmacokinetics of 9-nitrocamptothecin encapsulated in PLGA nanoparticles with different size via oral administration.
    Ru G; Han L; Qing J; Sheng J; Li R; Qiu M; Wang J
    Drug Deliv; 2016 Nov; 23(9):3417-3423. PubMed ID: 27174642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation, characterization, and in vivo study of rhein-loaded poly(lactic-co-glycolic acid) nanoparticles for oral delivery.
    Yuan Z; Gu X
    Drug Des Devel Ther; 2015; 9():2301-9. PubMed ID: 25960633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of different stabilizers on the encapsulation of desmopressin acetate into PLGA nanoparticles.
    Primavessy D; Günday Türeli N; Schneider M
    Eur J Pharm Biopharm; 2017 Sep; 118():48-55. PubMed ID: 28011093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled release of drug and better bioavailability using poly(lactic acid-co-glycolic acid) nanoparticles.
    Pandey SK; Patel DK; Maurya AK; Thakur R; Mishra DP; Vinayak M; Haldar C; Maiti P
    Int J Biol Macromol; 2016 Aug; 89():99-110. PubMed ID: 27112980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations.
    Salama AH; Mahmoud AA; Kamel R
    AAPS PharmSciTech; 2016 Oct; 17(5):1159-72. PubMed ID: 26589410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.
    Ignjatović NL; Penov-Gaši KM; Wu VM; Ajduković JJ; Kojić VV; Vasiljević-Radović D; Kuzmanović M; Uskoković V; Uskoković DP
    Colloids Surf B Biointerfaces; 2016 Dec; 148():629-639. PubMed ID: 27694053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.